Medtronic prevails over Boston Sci in patent suit

Medtronic has won a lawsuit it filed to prove it wasn't violating patents controlled by Boston Scientific. U.S. District Judge Sue Robinson in Wilmington, DE, said that Medtronic implantable defibrillators, including the InSync, Concerto and Consulta brands, weren't infringing two patents owned by Mirowski Family Ventures and licensed to Boston Scientific. She upheld the validity of the patents. Item

Suggested Articles

Akoya Biosciences raised $50 million to help boost its commercialization in research, drug development and clinical testing markets.

The dream of a comfortable, tabletop blood testing device, needing only a few drops taken from a finger and a handful of minutes, has now arrived.

Novartis is now teaming up with Amazon’s mammoth cloud computing division to overhaul its manufacturing, supply and business operations.